Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study Evaluating the Effectiveness of Typology-based Coaching on Therapy Management for Patients With HRpos/HER2neg Early Breast Cancer Under Adjuvant Treatment With Ribociclib

NCT07708571 is registered in ClinicalTrials.gov with Institut fuer Frauengesundheit as lead sponsor.

NCT NCT07708571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07708571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study Evaluating the Effectiveness of Typology-based Coaching on Therapy Management for Patients With HRpos/HER2neg Early Breast Cancer Under Adjuvant Treatment With Ribociclib
Lead sponsor
Institut fuer Frauengesundheit
Phase
Not applicable
Overall status
Recruiting
Start date
November 4, 2025
Completion date
June 30, 2030
Enrollment
548 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hr+/her2- early breast cancer